ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Brawn Biotech declared related party transaction filing under Regulation 23(9) non-applicable for FY 2025-26. Its paid-up capital and net worth are below the exemption thresholds.
Brawn Biotech Ltd reported revenue from operations of ₹5.6 Cr (+14.3% YoY) and net profit of ₹0 Cr for Q2 FY27.
Brawn Biotech intimated a board meeting on 05 Nov 2026 to consider un-audited Q2 FY27 results. The trading window stays closed till 16 Nov 2026.
Brawn Biotech Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026. The filing includes details on promoter and public shareholding.